These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32768078)

  • 1. A 59-Year-Old Woman With Shortness of Breath and Chest Pain.
    Duvvuri PD; Liu J; Bhardwaj C
    Chest; 2020 Aug; 158(2):e65-e69. PubMed ID: 32768078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mixed connective tissue disease with pulmonary hypertension developing in a chronic myeloid leukemia patient on dasatinib treatment].
    Watanuki S; Kikuchi T; Toyama T; Abe R; Nakayama H; Karigane D; Shimizu T; Kikuchi J; Matsumoto K; Yasuoka H; Kataoka M; Okamoto S; Mori T
    Rinsho Ketsueki; 2018; 59(2):174-177. PubMed ID: 29515069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of pulmonary arterial hypertension during oral dasatinib therapy for chronic myelogenous leukemia].
    Morishita S; Hagihara M; Itabashi M; Ishii Y; Yamamoto W; Numata A; Motohashi K; Matsumoto K; Fujisawa S; Nakajima H
    Rinsho Ketsueki; 2016 Aug; 57(8):999-1003. PubMed ID: 27599415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic myeloid leukemia complicated by pulmonary hypertension during dasatinib therapy: a single-center retrospective study].
    Edahiro Y; Takaku T; Konishi H; Tsukune Y; Fujioka I; Takasu K; Gotoh A; Daida H; Komatsu N
    Rinsho Ketsueki; 2017; 58(11):2213-2218. PubMed ID: 29212971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia.
    Hong JH; Lee SE; Choi SY; Kim SH; Jang EJ; Bang JH; Park JE; Jeon HR; Oh YJ; Yi JE; Jung HO; Youn HJ; Kim DW
    Cancer Res Treat; 2015 Oct; 47(4):937-42. PubMed ID: 25648097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reversible dasatinib-related pulmonary arterial hypertension in a CML patient].
    Nagasaki J; Aoyama Y; Nomoto Y; Ido K; Ichihara H; Mugitani A
    Rinsho Ketsueki; 2016 May; 57(5):618-23. PubMed ID: 27263788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Case of Drug-Induced Organizing Pneumonia Caused by Dasatinib].
    Sato M; Watanabe S; Aoki N; Asakawa K; Moriyama H; Oshima Y; Koya T; Okazuka K; Kikuchi T
    Gan To Kagaku Ryoho; 2018 May; 45(5):851-854. PubMed ID: 30026450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 68-Year-Old Man With Chronic Myelogenous Leukemia and a Large Unilateral Pleural Effusion.
    Alter A; Chaisson N; Mukherjee S; Gildea T
    Chest; 2018 Feb; 153(2):e33-e36. PubMed ID: 29406237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dasatinib-induced pulmonary arterial hypertension - A rare late complication.
    Ibrahim U; Saqib A; Dhar V; Odaimi M
    J Oncol Pharm Pract; 2019 Apr; 25(3):727-730. PubMed ID: 29343154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary arterial hypertension in a patient treated with dasatinib: a case report.
    Skride A; Sablinskis M; Sablinskis K; Lesina K; Lejnieks A; Lejniece S
    J Med Case Rep; 2017 Dec; 11(1):362. PubMed ID: 29287600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary arterial hypertension caused by treatment with dasatinib for chronic myeloid leukemia -critical alert-.
    Sano M; Saotome M; Urushida T; Katoh H; Satoh H; Ohnishi K; Hayashi H
    Intern Med; 2012; 51(17):2337-40. PubMed ID: 22975544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 43-Year-Old Woman With Pleuritic Chest Pain, Shortness of Breath, and Weakness of All Extremities.
    Stein AP; Minish JM; Caulkins H; Patel DC; Ataya A
    Chest; 2022 Sep; 162(3):e117-e121. PubMed ID: 36088096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.
    Guignabert C; Phan C; Seferian A; Huertas A; Tu L; Thuillet R; Sattler C; Le Hiress M; Tamura Y; Jutant EM; Chaumais MC; Bouchet S; Manéglier B; Molimard M; Rousselot P; Sitbon O; Simonneau G; Montani D; Humbert M
    J Clin Invest; 2016 Sep; 126(9):3207-18. PubMed ID: 27482885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary arterial hypertension and chronic heart failure as dasatinib cardiotoxicity. A case report].
    Makeeva LM; Emelina EI; Gendlin GE; Nikitin IG; Vasyuk YA; Nesvetov VV
    Kardiologiia; 2017 Apr; 57(S4):53-60. PubMed ID: 29466183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible severe pulmonary hypertension secondary to dasatinib in a patient with chronic myeloid leukemia.
    Rasheed W; Flaim B; Seymour JF
    Leuk Res; 2009 Jun; 33(6):861-4. PubMed ID: 18986702
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical features of pulmonary arterial hypertension in patients receiving dasatinib.
    Shah NP; Wallis N; Farber HW; Mauro MJ; Wolf RA; Mattei D; Guha M; Rea D; Peacock A
    Am J Hematol; 2015 Nov; 90(11):1060-4. PubMed ID: 26284693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chylothorax: complication attributed to dasatinib use.
    Al-Abcha A; Iftikhar MH; Abu Rous F; Laird-Fick H
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31848139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chest pain, dyspnea, syncope].
    Laube I; Medici TC; Jenni R; Vetter W
    Praxis (Bern 1994); 1995 Jun; 84(23):703-7. PubMed ID: 7784777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dasatinib-induced Chylothorax in Chronic Myelogenous Leukemia in Pediatric Patient: Report of a Case and Review of Literature.
    Hickman K; Diaz E; Graham R; Adams R; Ngwube A
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e665-e667. PubMed ID: 31688632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is dasatinib-related pulmonary hypertension a clinical concern?
    Szmit S
    Future Oncol; 2015 Sep; 11(18):2491-4. PubMed ID: 26278893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.